These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34229159)

  • 21. Effectiveness and safety of Lacosamide in pediatric patients with epilepsy under four years: Results from a prospective cohort study in China.
    Xiong L; He H; Wang D; Liu T; Xiao N
    Seizure; 2024 May; 118():71-79. PubMed ID: 38643678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: The VITOBA study.
    Runge U; Arnold S; Brandt C; Reinhardt F; Kühn F; Isensee K; Ramirez F; Dedeken P; Lauterbach T; Noack-Rink M; Mayer T
    Epilepsia; 2015 Dec; 56(12):1921-30. PubMed ID: 26526971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness and safety of lacosamide in children with epilepsy in a clinical practice setting.
    Sanmartí-Vilaplana F; Díaz-Gómez A
    Epilepsy Behav; 2018 Feb; 79():130-137. PubMed ID: 29287216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, tolerability, and efficacy of adjunctive lacosamide in pediatric patients with epilepsy syndromes associated with generalized seizures: Phase 2, open-label exploratory trial.
    Auvin S; Arzimanoglou A; Beller C; Floricel F; Daniels T; Bozorg A
    Epilepsia; 2023 Nov; 64(11):2947-2957. PubMed ID: 37545406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study.
    Jin Y; Zhang R; Jiang J; Liu X
    Acta Neurol Belg; 2023 Jun; 123(3):1081-1087. PubMed ID: 37004703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of lacosamide in children: experience of a tertiary medical care center in Brazil.
    Romão TT; Angelim AIM; Prado HJPD; Goes FV; Pires MEP; Fontana RDS; Pires LC; Fernandes AR; D'Andrea-Meira I
    Arq Neuropsiquiatr; 2022 Nov; 80(11):1090-1096. PubMed ID: 36577407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lacosamide: A Review in Focal-Onset Seizures in Patients with Epilepsy.
    Hoy SM
    CNS Drugs; 2018 May; 32(5):473-484. PubMed ID: 29785508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lacosamide monotherapy in clinical practice: A retrospective chart review.
    Villanueva V; Giráldez BG; Toledo M; De Haan GJ; Cumbo E; Gambardella A; De Backer M; Joeres L; Brunnert M; Dedeken P; Serratosa J
    Acta Neurol Scand; 2018 Sep; 138(3):186-194. PubMed ID: 29542107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients.
    Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M
    Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early add-on lacosamide in a real-life setting: results of the REALLY study.
    Villanueva V; Garcés M; López-Gomáriz E; Serratosa JM; González-Giráldez B; Parra J; Rodríguez-Uranga J; Toledo M; López González FJ; Bermejo P; Giner P; Castillo A; Molins A; Campos D; Mauri JÁ; Muñoz R; Bonet M; Serrano-Castro P; del Villar A; Saiz-Díaz RA;
    Clin Drug Investig; 2015 Feb; 35(2):121-31. PubMed ID: 25488477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures.
    García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A
    Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real life pharmaceutical treatment patterns for adult patients with focal epilepsy in Germany: a longitudinal and cross-sectional analysis of recently approved anti-epileptic drugs.
    Groth A; Wilke T; Borghs S; Gille P; Joeres L
    Ger Med Sci; 2017; 15():Doc09. PubMed ID: 28638313
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical impact of the dose and blood concentration of lacosamide in Japanese pediatric patients with epilepsy: A cohort study.
    Ishikawa N; Eguchi Y; Izumo H; Tateishi Y; Tani H; Kobayashi Y; Okada S
    Epilepsy Behav; 2022 Apr; 129():108614. PubMed ID: 35203014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of adjunctive lacosamide in Chinese and Japanese adults with epilepsy and focal seizures: A long-term, open-label extension of a randomized, controlled trial.
    Inoue Y; Liao W; Wang X; Du X; Tennigkeit F; Sasamoto H; Osakabe T; Hoshii N; Yuen N; Hong Z
    Epilepsy Res; 2021 Oct; 176():106705. PubMed ID: 34246118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcomes of perampanel vs. lacosamide in cohorts of consecutive patients with severely refractory epilepsies - A monocentric retrospective analysis of systematically collected data from the German Kork Epilepsy Center.
    Kurth C; Kockelmann E; Steinhoff BJ
    Seizure; 2017 Feb; 45():47-51. PubMed ID: 27915111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center.
    Baker MD; Abou-Khalil BW; Arain A; Tummala P; Azar NJ; Haas KF; Sonmezturk HH
    Clin Neurol Neurosurg; 2018 Aug; 171():179-183. PubMed ID: 29929174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?
    Brodie MJ; Kelly K; Stephen LJ
    Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjunctive lacosamide--5 years' clinical experience.
    Stephen LJ; Kelly K; Parker P; Brodie MJ
    Epilepsy Res; 2014 Oct; 108(8):1385-91. PubMed ID: 25064538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study.
    Roberti R; Di Gennaro G; Anzellotti F; Arnaldi D; Belcastro V; Beretta S; Boero G; Bonanni P; Canafoglia L; D'Aniello A; Dainese F; De Caro C; Di Gennaro G; Di Giacomo R; DiFrancesco JC; Dono F; Falcicchio G; Ferlazzo E; Foschi N; Franciotta S; Gambardella A; Giordano A; Iannone LF; Labate A; La Neve A; Lattanzi S; Leggio U; Liguori C; Maschio M; Nilo A; Operto FF; Pascarella A; Pauletto G; Renna R; Strigaro G; ; Russo E
    Epilepsia; 2024 Feb; 65(2):456-472. PubMed ID: 38052481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.